FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma

AIMode News Desk · curated summary

August 13, 20261 min readHealth

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

Related coverage: FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma Targeted Oncology

About this story

This story was aggregated from Targeted Oncology. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.

Read the full story →

For agents:JSON record OpenAPI WebMCP llms.txt

More in Health

Health

BMS wins first FDA approval for oral CELMoD in MM

Related coverage: BMS wins first FDA approval for oral CELMoD in MM FirstWord Pharma

FirstWord Pharma · 2 hours ago

Health

Hyundai Hope on Wheels donates $100K to USA Health Children’s and Women’s Hospital

Related coverage: Hyundai Hope on Wheels donates $100K to USA Health Children’s and Women’s Hospital fox10tv.com

fox10tv.com · 2 hours ago

Health

Regional differences in chemotherapy treatment for breast cancer may affect survival, Swedish study finds

Related coverage: Regional differences in chemotherapy treatment for breast cancer may affect survival, Swedish study finds Medical Xpress

Medical Xpress · 3 hours ago

Health

Wisconsin DHS confirms 13 more measles cases in Iowa, Lafayette counties

Related coverage: Wisconsin DHS confirms 13 more measles cases in Iowa, Lafayette counties Channel 3000 Measles cases surge to 15 in Iowa and Lafayette counties as Wisconsin warns of more spread WISN McLennan County man gets life in double capital murder trial with motorcycle club links Waco Tribune-Herald Measles cases spike from 2 to 15 in southwestern Wisconsin WKOW BREAKING: Measles outbreak confirmed in southwest Wisconsin with 13 new cases reported wtmj.com

Channel 3000 · 3 hours ago